lowdensity lipoprotein cholesterol ldl c (Elabscience Biotechnology)
Elabscience Biotechnology is a verified supplier 
Elabscience Biotechnology manufactures this product 
96
Structured Review
Elabscience Biotechnology
lowdensity lipoprotein cholesterol ldl c
Lowdensity Lipoprotein Cholesterol Ldl C, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 195 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lowdensity+lipoprotein+cholesterol+ldl+c/Triglyceride+(TG)+Colorimetric+Assay+Kit+(Single+Reagent/pm41951010-83-20-33
Average 96 stars, based on 195 article reviews
Lowdensity Lipoprotein Cholesterol Ldl C, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 195 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lowdensity+lipoprotein+cholesterol+ldl+c/Triglyceride+(TG)+Colorimetric+Assay+Kit+(Single+Reagent/pm41951010-83-20-33
Average 96 stars, based on 195 article reviews
lowdensity lipoprotein cholesterol ldl c - by Bioz Stars,
2026-11
96/100 stars
Images
Related Articles
other:Article Title: Hepatic GAL1 deficiency alleviates steatosis via WWP2-mediated PARP1 degradation and activation of the SIRT1-CPT1A pathway. Article Snippet: Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent chronic liver disease worldwide and is closely associated with obesity, diabetes, and other metabolic disorders.. Because MASLD progression poses serious health risks, elucidating the underlying mechanisms is essential to guide early intervention and therapeutic strategies.. Methods: Proteomic analysis was used to identity high-fat diet (HFD)-induced proteins in mouse liver. Article Title: Cooperative action of non-digestible oligosaccharides improves lipid metabolism of high-fat diet-induced mice. Article Snippet: Non-digestible oligosaccharides are known to exert health-promoting effects.. However, the specific mechanisms by which they regulate host physiology remain unclear.. Understanding these mechanisms will facilitate the development of non-digestible oligosaccharide compositions that can achieve synergistic effects. Article Title: Tetramethylpyrazine: A fermented alcohol product that mitigates alcoholic liver disease in mice. Article Snippet: Alcoholic liver disease (ALD) is a leading cause of premature death globally yet remains under-controlled.. In this study, we investigated the protective effects of tetramethylpyrazine (TMP), an aromatic compound found in fermented alcohol, against ALD in a National Institute on Alcohol Abuse and Alcoholism (NIAAA) mice model. Our results demonstrated that TMP significantly reduced alcohol-induced liver injury, steatosis, oxidative stress, and mitochondrial damage, while restoring NAD levels and the NAD/NADH ratio, increasing ATP production, regulating energy metabolism disorders, and restoring metabolic balance (P < 0.05).. Liver transcriptomic analysis identified 906 ALD-associated genes enriched in energy and lipid metabolism pathways, with a molecular signature of NAD-dependent oxidoreductase activity. AST Assay:Article Title: Multiscale insights into cornuside's effects on NAFLD: A cross-disciplinary integrating bioinformatics, computational chemistry, and machine learning. Article Snippet: Background: Non-alcoholic fatty liver disease (NAFLD) is a complex metabolic disorder involving intertwined signaling pathways, posing challenges for targeted therapeutic interventions.. Cornus Fructus (CF), a traditional medicinal herb, holds potential for NAFLD treatment, with cornuside (COR) identified as its primary active |